Abstract
Introduction
Recent research has suggested a possible link between toxoplasmic agents and schizophrenia. We aimed to assess this by measuring Toxoplasma gondii-associated antibodies in schizophrenia patients and controls
Methods
We used a commercially available enzyme-linked immunosorbent assay (ELISA) kit to measure the level of immunoglobulin G (IgG) and IgM antibodies in serum samples from schizophrenia patients (n=40) and from a group of non-schizophrenic control subjects (n=37)
Results
Among schizophrenic patients, 16 (40%) showed IgG seropositivity and two (5%) showed IgM seropositivity. Among the control group, five (13.5%) were found have IgG seropositivity and one (2.7%) showed IgM seropositivity. In our study we found that IgG T gondii antibodies were significantly higher in schizophrenia patients compared with controls
Conclusions
This study supports the theory that toxoplasmic agents may have a role in the aetiology of schizophrenia
Similar content being viewed by others
References
Buka SL, Tsuang MT, Torrey EF, Klebanoff MA, Bernstein D, Yolken RH. Maternal infections and subsequent psychosis among offspring. Arch Gen Psychiatry. 2001;58:1032–1037.
Leweke FM, Gerth CW, Koethe D, et al. Antibodies to infectious agents in individuals with recent onset schizophrenia. Eur Arch Psychiatry Clin Neurosci. 2004;254:4–8.
Susser E, Hoaek HW, Brown A. Neurodevelopmental disorders after prenatal famine: the story of the Dutch Famine Study. Am J Epidemiol. 1998;147:213–216.
Mortensen PB, Nørgaard-Pedersen B, Waltoft BL, Sørensen TL, Hougaard D, Yolken RH. Early infections of Toxoplasma gondii and the later development of schizophrenia. Schizophr Bull. 2007;33:741–744.
Flegr J, Preiss M, Klose J, Havlicek J, Vitakova M, Kodym P. Decreased level of psychobiological factor novelty seeking and lower intelligence in men latently infected with the protozoan parasite Toxoplasma gondii dopamine, a missing link between schizophrenia and toxoplasmosis? Biol Psychol. 2003;63:253–268.
Amminger GP, McGorry PD, Berger GE, et al. Antibodies to infectious agents in individuals at ultra-high risk for psychosis. Biol Psychiatry. 2007;61:1215–1217.
Brown AS, Schaefer CA, Quesenberry CP, Liu L, Babulas VP, Susser ES. Maternal exposure to toxoplasmosis and risk of schizophrenia in adult offspring. Am J Psychiatry. 2005;162:767–773.
Jackson MH, Hutchinson WM. The prevelance and source of Toxoplasma infection in the environment. Adv Parasitol. 1989;28:55–105.
Bachmann S, Schröder J, Bottmer C, Torrey EF, Yolken RH. Psychopathology in first-episode schizophrenia and antibodies to Toxoplasma gondii. Psychopathology. 2005;38:87–90.
Skallova A, Kodym P, Frynta D, Flegr J. The role of dopamine in Toxoplasma-induced behavioral alterations in mice: an ethological and ethopharmacological study. Parasitology. 2006;2:1–11.
First M, Spitzer R, Gibbon M, Williams J. Structured Clinical Interview for DSM-IV Axis 1 Disorders (SCID-1), Clinical Version. Washington DC: American Psychiatric Publishing, Inc; 1977.
Niebuhr DW, Millikan AM, Cowan DN, Yolken R, Li Y, Weber NS. Selected infectious agents and risk of schizophrenia among U.S. military personnel. Am J Psychiatry. 2008;165:99–106
Li Q, Luo XL. Controlled study of schizophrenia and affective disorders and Toxoplasma infection. Acta Acad Med Hubei. 1999;20:223–225.
Yolken RH, Bachmann S, Rouslanova I, et al. Antibodies Toxoplasma gondii in individuals with first-episode schizophrenia. Clin Infect Dis. 2001;32:842–844.
Torrey EF, Yolken RH. Could schizophrenia be a viral zoonosis transmitted from house cats? Schizophr Bull. 1995;21:167–171.
Torrey EF, Rawlings R, Yolken RH. The antecedents of psychoses: a case control study of selected risk factors. Schizophr Res. 2000;46:17–23.
Holliman RE. Toxoplasmosis, behavior and personality. J Infect. 1997;35:105–110.
Ledgerwood LG, Ewald PW, Cochran GM. Genes, germs and schizophrenia an evolutionary perspective. Perspect Biol Med. 2003;46:317–348.
Flegr J, Hrdy I. Influence of chronic toxoplasmosis on some human personality factors. Folia Parasitol (Praha). 1994;41:122–126.
Jones-Brando L, Torrey EF, Yolken R. Drugs used in the treatment of schizophrenia and bipolar disorder inhibit the replication of Toxoplasma gondii. Schizophr Res. 2003;62:237–244.
Conejero-Goldberg C, Torrey EF, Yolken RH. Herpesviruses and Toxoplasma gondii in orbital frontal cortex of psychiatric patients. Schizophr Res. 2003;60:65–69.
Selten JP, Kahn RS. Schizophrenia after prenatal exposure to Toxoplasma gondii? Clin Infect Dis. 2002;35:633–634.
Torrey EF, Yolken RH. Schizophrenia and toxoplasmosis. Schizophr Bull. 2007;33:727–728.
Zhu S, Guo MF, Feng QC, Fan JM, Zhang LX. Epidemiological evidences from China assume that psychiatric-related diseases may be associated with Toxoplasma gondii infection. Neuro Endocrinol Lett. 2007;28:115–120.
Cetinkaya Z, Yazar S, Gecici O, Namli MN. Anti-Toxoplasma gondii antibodies in patients with schizophrenia — preliminary findings in a Turkish sample. Schizophr Bull. 2007;33:789–791.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Tamer, G.S., Dundar, D., Yalug, I. et al. The schizophrenia and Toxoplasma gondii connection: Infectious, immune or both?. Adv Therapy 25, 703–709 (2008). https://doi.org/10.1007/s12325-008-0063-5
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12325-008-0063-5